GSK plc

Equities

GSK

GB00BN7SWP63

Market Closed - London S.E. Other stock markets 11:35:18 2025-12-12 am EST			5-day change	1st Jan Change
1,824.50 ^GBX	+0.19%		-0.08%	+35.50%

02:30pm	US FDA approves Innoviva's oral antibiotic for gonorrhea	RE
11:55am	Surprise UK GDP Contraction Keeps FTSE 100 in the Red	MT

Transcript : GSK plc Presents at Goldman Sachs 44th Annual Global Healthcare Conference, Jun-13-2023 09

Published on 06/13/2023 at 12:20 pm EDT

S&P Capital IQ

Presenter Speech
Chris Shibutani (Analysts)

And we're back. Welcome, everybody, to our third session this morning at the Goldman Sachs Healthcare Conference. My name is Chris Shibutani along with the

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about GSK plc

02:30pm	US FDA approves Innoviva's oral antibiotic for gonorrhea	RE
11:55am	Surprise UK GDP Contraction Keeps FTSE 100 in the Red	MT
11:50am	GSK plc Presents at Citi Annual Global Healthcare Conference 2025, Dec-04-2025
10:06am	GSK Says Depemokimab Recommended for EU Approval in Asthma, Rhinosinusitis	MT
09:24am	GSK hails positive opinion by EU's CHMP on depemokimab and Nucala	AN
09:27am	European health regulator recommends approval for GSK's twice-yearly asthma drug	RE
10:39am	Arcus scraps late-stage cancer trial after weak survival data	RE
05:33am	GSK Says European Health Agency's Committee Recommends Expanded Approval for RSV Vaccine in Europe	MT
05:06am	GSK Gets US FDA Approval for Gepotidacin to Treat Uncomplicated Urogenital Gonorrhoea	MT
04:23am	GSK's Arexvy on track for wider age range approval in Europe	AN
02:44am	FTSE 100 to rise, UK GDP down, trade deficit spikes	AN
02:35am	GSK's RSV Vaccine Bags European Recommendation for Expanded Use	MT
02:28am	GSK gets EU regulator backing for expanded use of RSV vaccine	RE
02:15am	GSK announces positive CHMP opinion on Arexvy for all adults aged 18 and above	RE
03:06am	UK Stocks-Factors to watch on December 12	RE
11:22pm	GSK Wins US FDA Approval for Uncomplicated Urogenital Gonorrhoea Antibiotic	MT
Dec. 11	GSK Says FDA Approved Oral Treatment for Gonorrhea	DJ
Dec. 11	GSK plc Announces US FDA Approval Of Blujepa For Gonorrhoea Indication	CI
Dec. 11	FDA approves BluJepa for uncomplicated urogenital gonorrhea in some patients	RE
Dec. 11	US FDA expands use of GSK's Blujepa as treatment for gonorrhea	RE
Dec. 11	Fda: approves blujepa for uncomplicated urogenital gonorrhea in some adult & pediatric patients 12 years of age & older - website	RE
Dec. 11	Outgoing GSK CEO Emma Walmsley declares US best place to invest	AN
Dec. 10	Sector Update: Health Care Stocks Rise Premarket Wednesday	MT
Dec. 10	GSK Bolsters Oncology Pipeline with New US FDA Designation, Oxford BioTherapeutics Partnership	MT
Dec. 10	GSK Says Risvutatug Rezetecan Gets FDA Orphan Drug Designation For Small-Cell Lung Cancer Treatment	MT